LEADER 01385nam  2200373Ia 450 
001 9910698135403321
005 20090320145929.0
035   $a(CKB)5470000002395628
035   $a(OCoLC)316566784
035   $a(EXLCZ)995470000002395628
100   $a20090320d2009      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $eanimal models : essential elements to address efficacy under the animal rule
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) :$cCenter for Biologics Evaluation and Research (CBER),$d[2009]
215   $a19 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on Mar. 20, 2009).
300   $a"Draft guidance."
300   $a"January 2009."
517   $aGuidance for industry 
606   $aLaboratory animals
606   $aDrugs$xEffectiveness
615  0$aLaboratory animals.
615  0$aDrugs$xEffectiveness.
712 02$aCenter for Drug Evaluation and Research (U.S.)
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bXZL4
906   $aBOOK
912   $a9910698135403321
996   $aGuidance for industry$93434577
997   $aUNINA